Freeline Therapeutics to be acquired by Syncona for $28.3M in cash
Post Content
Similar Posts
Nvidia’s revenue triples as AI chip boom continues
Nvidia called for accelerating revenue growth in the next quarter, even as executives warn that government limits on sales to some countries will hurt results. Post Views: 128
Oracle shares edge down in mixed market conditions
Post Content Post Views: 103
India’s bond market set for growth with central bank rate cuts
Post Content Post Views: 114
Stifel Financial client assets slip in October amid lower equity markets
Post Content Post Views: 126
Biden hopeful about Israel-Hamas truce extension, US hostages release
Post Content Post Views: 114
US economic activity slowed in recent weeks, Fed survey shows
Post Content Post Views: 128